Lilly boosts immunotherapy pipeline with Armo BioSciences acquisition
Wednesday, July 25, 2018 - 12:21
in Mathematics & Economics
The drug company will pay $1.6 billion to gain Armo’s IL-10 program
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via